Danaher Corporation (NYSE:DHR) Shares Sold by Gouws Capital LLC

Key Points

• Gouws Capital LLC reduced its stake in Danaher Corporation by 33.3%, owning 17,888 shares after selling 8,914 shares during the first quarter, making the stock its 13th largest holding.
• Several institutional investors, including Vanguard Group and Bank of New York Mellon, increased their stakes in Danaher, with 79.05% of the stock currently owned by institutions.
• Danaher reported earnings of $1.80 per share, exceeding estimates, with a revenue of $5.94 billion for the last quarter, reflecting a 3.4% increase compared to the same period last year.

Gouws Capital LLC reduced its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 33.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 17,888 shares of the conglomerate's stock after selling 8,914 shares during the period. Danaher comprises approximately 2.2% of Gouws Capital LLC's portfolio, making the stock its 13th largest position. Gouws Capital LLC's holdings in Danaher were worth $3,667,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of DHR. GHP Investment Advisors Inc. increased its holdings in shares of Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after acquiring an additional 99 shares during the last quarter. Heck Capital Advisors LLC acquired a new position in Danaher in the fourth quarter valued at approximately $27,000. Sierra Ocean LLC increased its stake in Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after purchasing an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC acquired a new stake in Danaher during the first quarter worth approximately $31,000. Finally, Dunhill Financial LLC lifted its position in shares of Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after buying an additional 67 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. UBS Group cut their target price on Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a research report on Wednesday, July 23rd. Robert W. Baird upped their target price on Danaher from $225.00 to $226.00 and gave the company an "outperform" rating in a research report on Friday, July 18th. TD Cowen lifted their price target on Danaher from $240.00 to $248.00 and gave the stock a "buy" rating in a research report on Wednesday, April 23rd. Finally, Scotiabank raised Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price objective for the company in a report on Friday, July 11th. Three analysts have rated the stock with a hold rating and eighteen have given a buy rating to the stock. According to MarketBeat, Danaher presently has a consensus rating of "Moderate Buy" and an average target price of $247.61.

Danaher Price Performance

Shares of DHR traded up $1.29 on Thursday, reaching $210.43. The stock had a trading volume of 2,634,386 shares, compared to its average volume of 4,253,022. The firm has a 50-day moving average of $199.27 and a 200 day moving average of $200.40. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $150.68 billion, a PE ratio of 44.77, a PEG ratio of 2.87 and a beta of 0.73. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping the consensus estimate of $1.64 by $0.16. The business had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business's revenue for the quarter was up 3.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.72 EPS. Sell-side analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.